Literature DB >> 2148805

Molecular and functional studies of recombinant soluble Fc gamma receptors.

C Sautès1, N Varin, P M Hogarth, J C Unkeless, C Teillaud, J Even, A Lynch, W H Fridman.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2148805     DOI: 10.1016/0161-5890(90)90023-s

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


× No keyword cloud information.
  6 in total

Review 1.  Murine soluble Fc gamma receptors/IgG-binding factors (IgG-BF): analysis of the relation to Fc gamma RII and production of milligram quantities of biologically active recombinant IgG-BF.

Authors:  C Sautès; N Mazières; A Galinha; E Tartour; C Bonnerot; S Amigorena; C Teillaud; R Spagnoli; W H Fridman
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  Lineage-specific alternative splicing of the human Fc gamma RIIA transmembrane exon requires sequences near the 3' splice site.

Authors:  M A Keller; S E McKenzie; D L Cassel; E F Rappaport; E Schwartz; S Surrey
Journal:  Gene Expr       Date:  1995

3.  The disulfide bridges of the immunoglobulin-like domains of Fc gamma RIIIB are essential for efficient expression and biological activity.

Authors:  B Enenkel; J Frey
Journal:  J Protein Chem       Date:  1993-08

4.  An alternative Fc gamma-receptor ligand: potential role in T-cell development.

Authors:  M Sandor; J Galon; L Takacs; Y Tatsumi; A L Mueller; C Sautes; R G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  Soluble FcgammaRIIa inhibits rheumatoid factor binding to immune complexes.

Authors:  Bruce D Wines; Amanda Gavin; Maree S Powell; Michael Steinitz; Russell R C Buchanan; P Mark Hogarth
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

6.  Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction.

Authors:  F L Ierino; M S Powell; I F McKenzie; P M Hogarth
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.